Woohoo!!!
I wish I knew that last week when filing a grant progress report. ;-)
But seriously Kei, that's wonderful news.
To jump on the momentum bandwagon, on Don's request, I've distilled
the Banff presentations and written a SfN abstract (due this Thu)
combining that as best I could with a summary of what Matthias & Don
had written already.
SfN abstract limits are measured in characters (2300 chars - minus
white space) - but including title, abstract, authors, and address.
This current summary at the top of the Google Doc we'd been nurturing
through last week (http://docs.google.com/Doc?id=dgk2mvhp_0fmftbb) is
now up to ~3800 chars without authors and addresses (NOTE: citations
are not necessary, nor are they typical for SfN abstract submissions).
Right now, Don, Matthias, Alan, Susie, and I all have access rights
to the doc. Anyone wishing to participate, please don't hesitate to
ask to be added to the list of collaborators. All you need to do is
pass on an active Google account email, and any one of us can add you
as a collaborator. If you don't want "write" access but only want to
read what's there, you can be added as a 'viewer'. They've also
recently added the ability to add all the members of a mailing list
as collaborators or viewers (up to 200 people - and only 10 can edit
simultaneously - see http://docs.google.com/support/bin/answer.py?
answer=66343&topic=8628)
Hopefully, this summary abstract can provide a final high-water mark
from which over the next few days we can distill a trimmed abstract
coming in under the wire.
To be honest, I think we have enough here for 2 SfN submissions - but
I'm not certain yet how to split it - or whether we should just trim
it to one. We'd also need a second SfN member/sponsor to be first
author beyond what Don has committed to do for this abstract. I'm
committed on another abstract, and you can only be "presenting"/first
author on one abstract. "Presenting"/first authors must be SfN full
or student members.
We should also give some thought as to which sessions we'd want to
submit to, and whether we'd want to request to give a talk or a
poster. The typical thing when you have >1 submission on a related
research effort is to have one of each.
Congratulations again to all - both on the successful Banff demo,
Banff HCLS session, and the actual publication of the BMC manuscript!
Cheers,
Bill
On May 12, 2007, at 3:41 PM, Kei Cheung wrote:
Adding to the milestones, the SWHCLS paper was just officially
published in the special issue "Semantic e-Science in Biomedicine"
of BMC Bioinformatics. See the URL below.
http://www.biomedcentral.com/1471-2105/8/S3/S2
Let's keep the momentum going!
Cheers,
-Kei
William Bug wrote:
Vunderbar!
Thanks to all who worked hard to pull this off!
It's hard to get the full impact just perusing the slides, but it
looks to me that you pulled together a very compelling demo that
examined several questions of biological relevance to
neuroscientists studying neurodegenerative disease (AD in
particular).
I also really like the list breakdown of tools to target different
aspects of the overall development - e.g., Pellet, Jena, Perfuse,
etc.
I think this will be a fantastic base to build off for ISMB (and
SfN).
Kudos!
Cheers,
Bill
On May 11, 2007, at 2:18 PM, Alan Ruttenberg wrote:
I have updated the page http://esw.w3.org/topic/HCLS/
Banff2007Demo with slides, pointers to the triple store etc.
-Alan
Bill Bug
Senior Research Analyst/Ontological Engineer
Laboratory for Bioimaging & Anatomical Informatics
www.neuroterrain.org
Department of Neurobiology & Anatomy
Drexel University College of Medicine
2900 Queen Lane
Philadelphia, PA 19129
215 991 8430 (ph)
610 457 0443 (mobile)
215 843 9367 (fax)
Please Note: I now have a new email - [EMAIL PROTECTED]
<mailto:[EMAIL PROTECTED]>
Bill Bug
Senior Research Analyst/Ontological Engineer
Laboratory for Bioimaging & Anatomical Informatics
www.neuroterrain.org
Department of Neurobiology & Anatomy
Drexel University College of Medicine
2900 Queen Lane
Philadelphia, PA 19129
215 991 8430 (ph)
610 457 0443 (mobile)
215 843 9367 (fax)
Please Note: I now have a new email - [EMAIL PROTECTED]
